• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Sally Ramadan, PharmD

Latest:

Pharmaceutical Care Services for Patients With Diabetes: A Systematic Scoping Review

Major databases were systematically searched for articles reporting on pharmaceutical care services for patients with diabetes, and 86 pharmaceutical care services were qualitatively synthesized.


Alana Hippensteele

Latest:

Rising Incidence of Young-Onset Cancer: Causes and Generational Risk Factors

At ESMO Congress 2024, Shuji Ogino, MD, PhD, MS, explained that the rising incidence of young-onset cancer may be due to generational risk factors such as lifestyle, diet, and environmental changes, emphasizing the need for long-term research and follow up to understand early-life influences on cancer development.


Kelly A. Wolgast, DNP

Latest:

A Multistakeholder Effort in Pennsylvania to Improve the Accuracy of Reporting Fatal Drug Overdoses

The authors describe a novel training program for death certifiers in Pennsylvania, which has been designed to specifically focus on some of the main challenges in the death certification process and resulted in a useful model that can potentially be adopted by other states or municipalities.


Alexandra Scott, MA

Latest:

Characterizing Obesity in a Large Health Care Delivery System.

The prevalence of obesity in the Sutter Health system between 2015 and 2020 was 35%. Differences by race/ethnicity, health insurance, smoking status, and comorbidities were examined.


Michelle Skornicki, MPH

Latest:

Economic Burden of Joint Disease in Psoriasis: US Claims Analysis

This retrospective claims analysis found that concomitant joint disease in psoriasis is associated with greater health care resource utilization and health care costs than psoriasis alone.


Jenna Napoleone, PhD, MPH

Latest:

Modeling the Economic Value of Cardiometabolic Virtual-First Care Programs

Using a microsimulation approach, this study modeled the potential multiyear health and economic benefits of participating in cardiometabolic virtual-first care programs.


Jianhui Hu, PhD

Latest:

Properties of the Overall Hospital Star Ratings and Consumer Choice

The CMS Star Ratings may be of limited value for patients choosing hospitals for specific care needs.


Ariana Pelosci

Latest:

Ide-Cel Generates Durable Responses in Functionally High-Risk Myeloma

In April, the FDA approved decabtagene vicleucel (ide-cel) for earlier treatment of relapsed/refractory multiple myleoma.


Paulette Spencer, MPH, MA

Latest:

Community Health Workers’ Critical Role in Trust Building Between the Medical System and Communities of Color

The authors interrogate elements of routine medical practice in New York City to argue for reforms of hospital culture through relational trust-building capabilities of community health workers.


Michael Cantor, MD

Latest:

The Promising Future of Alzheimer Disease Treatment

Panelists conclude the discussion with personal insight into the promising future of Alzheimer disease treatment.


Zhanette H. Coffee, MSN

Latest:

Prolonged Cessation of Chronic Opioid Analgesic Therapy: A Multidisciplinary Intervention

This article evaluates the immediate and long-term efficacy of a group multidisciplinary program for chronic opioid analgesic therapy cessation in the setting of chronic, noncancer pain.


Joaquim Cristino, MSc

Latest:

Sacubitril/Valsartan in Medicare Alternative Payment Models

Optimizing utilization of sacubitril/valsartan for treatment of heart failure could improve provider performance in the Bundled Payments for Care Improvement initiative and the Medicare Shared Savings Program.


Nick Sutingco, MD

Latest:

Service Line Care Delivery Model for COVID-19 Patient-Centric Care

The authors provide steps hospitals can take to align their care delivery model to effectively meet the demands of a public health crisis such as the current pandemic.


Noah Stansfield

Latest:

Myasthenia Gravis Trial Set for CAR T CABA-201

The chimeric antigen receptor T-cell therapy (CAR T) from Cabaletta Bio has already been cleared for trials in systemic lupus erythematosus, myositis, and systemic sclerosis.


Jessica Walradt, MS, BA

Latest:

Policy Solutions to Facilitate the New eCQM ACO Reporting and Advancement of Interoperability

This article describes the challenges associated with aggregating and reporting quality data via electronic health records and discusses corresponding policy solutions.


Emma K. Harrington, PhD

Latest:

Discharge Prescribing and Subsequent Opioid Use After Traumatic Musculoskeletal Injury

The authors use surgical resident assignment as an instrumental variable for discharge opioid prescribing and estimate the impact of discharge opioid supply on subsequent use.


Neil Wagle, MD, MBA

Latest:

A Clinical Pathway to Well-Being: Putting Patient Priorities at the Center of Care

Using patient priorities and converting them into treatment goals result in better primary care outcomes for Medicare patients.


Leah L. Zullig, PhD, MPH

Latest:

Association Between Low-Income Subsidies and Inequities in Orally Administered Antimyeloma Therapy Use

Medicare Part D low-income subsidies alone are insufficient to improve the uptake and equitable use of high-cost, orally administered antimyeloma therapy.


Jafar Dada, MD

Latest:

Mortality Risk Stratification Can Predict Readmissions but Not Length of Stay

Mortality risk stratification can identify patients at higher risk of mortality and readmissions for prevention strategies. Other patients should be the focus of length-of-stay reduction strategies.


Jeremy W. Bray, PhD

Latest:

Association of Opioid Utilization Management With Prescribing and Overdose

Opioid utilization management in Medicare was associated with mixed effects on opioid prescribing, and prior authorization was associated with a decreased likelihood of subsequent overdose.



Christina Larson Chebili, MA

Latest:

Chemotherapy-Induced Peripheral Neuropathy in Metastatic Breast Cancer Patients Initiating Intravenous Paclitaxel/nab-Paclitaxel

We examine the incidence and impact of chemotherapy induced peripheral neuropathy on clinical and economic outcomes in women with metastatic breast cancer initiating intravenous paclitaxel/nab-paclitaxel.


Leslie Chang Evertson, DNP, RN, GNP-BC

Latest:

Chronic Disease Management: Why Dementia Care Is Different

Because of its often slowly progressive nature, dementia is often included among chronic disease management programs. Yet, for many reasons, its management demands different approaches.


Jeffrey Turner, MD

Latest:

Future of Cardiorenal Metabolic Syndrome Management

Jeffrey Turner, MD; Nihar R. Desai, MD, MPH; and Om P. Ganda, MD, provide closing thoughts on the future of cardiorenal metabolic syndrome management.


Tsan-Yao Huang, PhD

Latest:

Clinic Price Reductions in a Tiered Total Cost Benefit Design

Findings of this evaluation of primary care clinic responses in a tiered total cost of care benefit design suggest that clinics respond by reducing prices.


Wenyan Ji, MA

Latest:

Interventional Analytics in Skilled Nursing Facilities Associated With Reduced Readmissions

A retrospective analysis of 30-day risk-adjusted readmission rates among skilled nursing facilities (SNFs) between 2017 and 2022 compared those that had implemented an interventional analytics platform and other SNFs.


Daniel Muñoz, MD, MPA

Latest:

Association of Physician Coordination With Interfacility Transfer Acceptance Timeliness

The authors reviewed physician-to-physician conversations during emergency transfer of patients with ST-segment elevation myocardial infarction and found that higher-quality physician coordination was associated with faster time to acceptance.


Shonda Vink, MPH

Latest:

Relationships Between Patient Portal Activation and Patient Satisfaction Scores Among CG-CAHPS and HCAHPS Respondents

Patients with activated patient portal accounts report higher patient satisfaction in respective dimensions of the Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG-CAHPS) and Hospital CAHPS (HCAHPS) surveys compared with patients without portal accounts.


Victoria Bratcher, MHA

Latest:

Stakeholder Insights on rtCGM in T2D Population Health Management

Leading payer and health system stakeholders reviewed literature and shared insights on the value of real-time continuous glucose monitoring (rtCGM) in type 2 diabetes (T2D) population health.


© 2024 MJH Life Sciences
AJMC®
All rights reserved.